Saturday, November 21, 2026
  • About Web3Wire
  • Web3Wire NFTs
  • .w3w TLD
  • $W3W Token
  • Web3Wire DAO
  • Media Network
  • RSS Feed
  • Contact Us
Web3Wire
No Result
View All Result
  • Home
  • Web3
    • Latest
    • AI
    • Business
    • Blockchain
    • Cryptocurrencies
    • Decentralized Finance
    • Metaverse
    • Non-Fungible Token
    • Press Release
  • Technology
    • Consumer Tech
    • Digital Fashion
    • Editor’s Choice
    • Guides
    • Stories
  • Coins
    • Top 10 Coins
    • Top 50 Coins
    • Top 100 Coins
    • All Coins
  • Exchanges
    • Top 10 Crypto Exchanges
    • Top 50 Crypto Exchanges
    • Top 100 Crypto Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks
  • Events
  • News
    • Latest Crypto News
    • Latest DeFi News
    • Latest Web3 News
  • Home
  • Web3
    • Latest
    • AI
    • Business
    • Blockchain
    • Cryptocurrencies
    • Decentralized Finance
    • Metaverse
    • Non-Fungible Token
    • Press Release
  • Technology
    • Consumer Tech
    • Digital Fashion
    • Editor’s Choice
    • Guides
    • Stories
  • Coins
    • Top 10 Coins
    • Top 50 Coins
    • Top 100 Coins
    • All Coins
  • Exchanges
    • Top 10 Crypto Exchanges
    • Top 50 Crypto Exchanges
    • Top 100 Crypto Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks
  • Events
  • News
    • Latest Crypto News
    • Latest DeFi News
    • Latest Web3 News
No Result
View All Result
Web3Wire
No Result
View All Result
Home Press Release GlobeNewswire

NeOnc Technologies Receives Pharma Tech Outlook’s Top Drug Delivery Platform Award for 2024

October 7, 2024
in GlobeNewswire
Reading Time: 8 mins read
5
SHARES
248
VIEWS
Share on TwitterShare on LinkedInShare on Facebook

WESTLAKE VILLAGE, Calif., Oct. 07, 2024 (GLOBE NEWSWIRE) — NeOnc Technologies Holdings, Inc., a clinical-stage medical biotechnology company, has been recognized by Pharma Tech Outlook as the Top Drug Delivery Platform of 2024.

NeOnc Technologies Receives Pharma Tech Outlook’s Top Drug Delivery Platform Award for 2024

According to the publisher of the leading industry magazine focused on breakthrough pharma technologies, the award was made in “recognition of NeOnc’s stellar reputation and trust among customers and industry peers, evident in the numerous nominations we received from our subscribers.”

“NeOnc emerged as a Top Company after an exhaustive evaluation by an expert panel of C-level executives, industry thought leaders, and our editorial board,” the publisher stated.

Along with the award, NeOnc was featured as the cover story in the recent edition of Pharma Tech Outlook. Entitled, A Novel Approach to Treating Brain Cancer, the article highlighted the ability of the NEO™ technology platform to produce novel drugs and delivery methods designed to overcome the persistent challenges in delivering chemotherapeutics through the blood-brain barrier.

NeOnc recently announced it has begun patient enrollment for the Phase II clinical trial of NEO100-02™, the company’s first of two drug candidates in clinical trials for various indications and patient populations. The trials are proceeding simultaneously under FDA Fast-Track and Investigational New Drug (IND) status. NeOnc expects the trials to provide the data required for regulatory validation and to advance its promising new drugs toward commercialization.

The Pharma Tech Outlook article discussed NeOnc’s innovative intranasal delivery method designed to allow drugs to bypass the challenging blood-brain barrier and enter the brain through the olfactory or trigeminal nerves.

“Our drug delivery platform represents a groundbreaking advancement in how we approach the treatment of Brain Cancer and CNS diseases,” said Amir Heshmatpour, executive chairman of NeOnc Technologies. “By bypassing the blood-brain barrier, our platform not only enhances the delivery of our current therapeutics but also paves the way for using standard-of-care drugs in the future. This capability could revolutionize how we deliver conjugate and chaperone therapies, providing new hope for patients battling brain tumors and CNS diseases.”

NeOnc’s novel intranasal delivery method for NEO100-02 offers an easier alternative for patients compared to traditional methods such as pills, injections, radiation, and surgery. Radiation treatment and chemotherapy for brain cancers and other central nervous system (CNS) diseases have traditionally been complex, time-consuming, and often result in poor prognoses. The difficulty in accessing these tumors surgically frequently results in significant neurological deficits.

Intranasal drug delivery is non-invasive and can be easily administered by or for the patient, including children. This approach can potentially reduce treatment costs and improve efficacy while avoiding the physical and emotional burden of intravenous chemotherapy and surgeries. Intranasal delivery can also enable rapid onset of action and avoid the decrease in efficacy due to first-pass metabolism.

The biotechnology advancements generated by NeOnc’s NEO drug development platform are the result of more than a decade of research at the University of Southern California (USC) by NeOnc founder and CEO, Dr. Chen, MD, Ph.D., and his medical and scientific teams. 

“We are deeply grateful to Pharma Tech Outlook’s editorial board and its expert panel of C-level executives and industry thought leaders for bringing attention to the importance of our NEO™ technology platform for treating CNS diseases,” commented Dr. Chen.

“They have further strengthened our confidence that our novel delivery method can provide oncology physicians and CNS chemotherapeutic manufacturers with the vehicle they have long sought for impacting the efficacy of their treatment protocols,” added Dr. Chen. “With this prestigious award, we are honored to be recognized for our efforts in addressing the unique challenges posed by brain cancers.”

NEO212 also addresses brain metastasis as the most common type of brain tumor. Primary cancers, such as lung, breast, and melanoma, often metastasize to the brain.

An estimated 8%-10% of patients with systemic cancers will develop brain metastases, representing approximately 200,000 new patients annually, according to the American Association of Neurological Surgeons. For patients with malignant brain tumors, the five-year relative survival rate following diagnosis remains at less than 36%.

These compelling factors are driving the pharma therapeutics market for brain metastasis to grow at a projected 7.8% CAGR to reach $6.9 billion by 2033.

About NeOnc Technologies Holdings

NeOnc Technologies is a privately held clinical stage life sciences company focused on developing and commercializing central nervous system therapeutics designed to address the persistent challenges in overcoming the blood-brain barrier.

The company’s NEO™ drug development platform has produced a portfolio of novel drug candidates and delivery methods with patent protections extending to 2038. These proprietary chemotherapy agents have demonstrated positive effects in laboratory tests on various types of cancers and in clinical trials treating malignant gliomas. NeOnc’s NEO100™ and NEO212™ therapeutics are in Phase I and II human clinical trials, and are advancing under FDA Fast-Track and Investigational New Drug (IND) status.

The company has exclusively licensed an extensive worldwide patent portfolio from the University of Southern California consisting of issued patents and pending applications related to NEO100, NEO212, and other products from the NeOnc patent family for multiple uses, including oncological and neurological conditions.

For more about NeOnc and its pioneering technology, visit neonc.com.  

NeOnc Company Contact: 
Amir F Heshmatpour 
Chairman & Managing Director
AFH Holding & Advisory, LLC
Malibu, CA. 90265
M: 310 721 4391
Email Contact

A photo accompanying this announcement is available at https://www.globenewswire.com/NewsRoom/AttachmentNg/0c301a97-ddfb-413c-b456-25391712d8a8

About Web3Wire
Web3Wire – Information, news, press releases, events and research articles about Web3, Metaverse, Blockchain, Artificial Intelligence, Cryptocurrencies, Decentralized Finance, NFTs and Gaming.
Visit Web3Wire for Web3 News and Events, Block3Wire for the latest Blockchain news and Meta3Wire to stay updated with Metaverse News.
ShareTweet1ShareSendShare2
Previous Post

LED Light Engine Market Expected to Reach $115.8 Billion by 2032

Next Post

Apache Software Foundation Announces Apache Cassandra® 5.0, the Most Advanced, Secure, and AI-Ready Cassandra Yet

Related Posts

Illinois Certifies WRAP’s Operational De-escalation Curriculum, Recognizing 5.5 Hours of State-Mandated Officer Training

Fi st state ce tificatio adva ces WRAP's pla ed t a sitio f om device sales to ecu i g t ai i g p og ams, suppo ti g a scalable hyb id model combi i g W apTactics™ digital lea i g, i -pe so p oficie...

Read moreDetails

GOWell Acquires WellSense to Expand Global Well Integrity and Fiber Optic Sensing Capabilities

SINGAPORE a d HOUSTON, Nov. 11, 2026 (GLOBE NEWSWIRE) -- GOWell E e gy Tech ology (NASDAQ: GOW) ("GOWell" o the “Compa y”), a global o e-stop-shop fo i ovative well loggi g solutio s i the e e gy secto , today a ou ced that its Si gapo...

Read moreDetails

ODDITY Tech Reports Third Quarter 2026 Results Ahead of Plan, Raises Full Year Net Revenue And Adjusted EBITDA Outlook

Thi d qua te et eve ue of $145 millio , dow app oximately 2% yea -ove -yea Thi d qua te adjusted EBITDA of $22 millio Thi d qua te et i come of $11 millio a d thi d qua te adjusted et i come of $18 millio...

Read moreDetails

AEKE Integrates AI-Powered Training Technology with Strength Equipment to Advance Smart Home Fitness

The AEKE S1 P o combi es i tellige t fit ess assessme ts, pe so alized wo kout pla i g, eal-time moveme t feedback, a d ve satile st e gth t ai i g equipme t i o e i teg ated home gym system.New Yo k,...

Read moreDetails

BEDELITE Fall Releases: Internationally Award-Winning Home Textiles to Warm Up Your November Space

Rialto, Califo ia, US, Nov. 11, 2026 (GLOBE NEWSWIRE) -- As Novembe olls i a d c isp autum ai settles i ou homes, it’s the pe fect time to ef esh sofas, beds a d cozy ooks with soft ew textiles. If you’ e shoppi g fo stylish, comfo...

Read moreDetails

VLANDO Expands Flower-Inspired Storage Lineup With New Jewelry, Beauty and Travel Organizers

The lifestyle sto age b a d b i gs its “Beauty Bloomi g” desig philosophy to Peo y, Rose a d O chid collectio s, offe i g disti ct solutio s fo eve yday o ga izatio a d t avel.Pomo a, Califo ia, U ited States, Nov....

Read moreDetails

MALACASA Introduces Three Distinctive Dinnerware Collections for Diverse Dining Styles

Leah, Ta a, a d Flo a a e th ee popula collectio s withi the b a d’s b oade a ge of po celai , sto ewa e, a d bo e chi a di e wa e.De ve , Colo ado, U ited States, Nov. 11, 2026...

Read moreDetails

Herb Meiner Champions Cultural Heritage Through BVR Group Asia’s Support for Indonesia Heritage Walk

De pasa , Bali, I do esia, Nov. 11, 2026 (GLOBE NEWSWIRE) -- Fo He b Mei e , Fou de of BVR G oup Asia, buildi g a busi ess is ot o ly about c eati g value th ough comme cial ve tu es, but also about...

Read moreDetails

AEKE Introduces All-in-One Smart Home Gym, Integrating Multiple Strength Training Functions into a Single System

The AEKE S1 P o combi es mo e tha 23 gym-style t ai i g fu ctio s, i tellige t wo kout guida ce a d a space-savi g desig to offe a ew app oach to home fit ess.Mad id, Spai , Nov. 11, 2026 (GLOBE NEWSWIRE)...

Read moreDetails

GDS to Report Third Quarter 2026 Financial Results Before the Open of the U.S. Market on November 25, 2026

SHANGHAI, Chi a, Nov. 11, 2026 (GLOBE NEWSWIRE) -- GDS Holdi gs Limited (“GDS Holdi gs”, “GDS” o the “Compa y”) (NASDAQ: GDS; HKEX: 9698), a leadi g develope a d ope ato of high-pe fo ma ce data ce te s i Chi a, today a ou ced that...

Read moreDetails
Web3Wire NFTs - The Web3 Collective

Web3Wire, $W3W Token and .w3w tld Whitepaper

Web3Wire, $W3W Token and .w3w tld Whitepaper

Claim your space in Web3 with .w3w Domain!

Web3Wire

Trending on Web3Wire

  • Singapore Blockchain Week 2026 Returns This November, Puts Singapore And Johor, Malaysia Cross-Border Digital Economy Opportunities In The Spotlight

    5 shares
    Share 2 Tweet 1
  • BlackBerry to Participate in Upcoming Investor Conferences

    5 shares
    Share 2 Tweet 1
  • THIEAUDIO Introduces Clairvoyance MKII: The Evolution of a Signature Sound

    5 shares
    Share 2 Tweet 1
  • The Corporate Bitcoin Treasury Model Is About to Face Its First Real Credit Cycle

    5 shares
    Share 2 Tweet 1
  • Buffalo Biodiesel Inc. Launches In-House BBD Commercial Utility Token on Base Mainnet for Product Settlement

    5 shares
    Share 2 Tweet 1
Join our Web3Wire Community!

Our newsletters are only twice a month, reaching around 10000+ Blockchain Companies, 800 Web3 VCs, 600 Blockchain Journalists and Media Houses.


* We wont pass your details on to anyone else and we hate spam as much as you do. By clicking the signup button you agree to our Terms of Use and Privacy Policy.

Web3Wire Podcasts

Upcoming Events

There are currently no events.

Latest on Web3Wire

  • Singapore Blockchain Week 2026 Returns This November, Puts Singapore And Johor, Malaysia Cross-Border Digital Economy Opportunities In The Spotlight
  • BlackBerry to Participate in Upcoming Investor Conferences
  • THIEAUDIO Introduces Clairvoyance MKII: The Evolution of a Signature Sound
  • The Corporate Bitcoin Treasury Model Is About to Face Its First Real Credit Cycle
  • Buffalo Biodiesel Inc. Launches In-House BBD Commercial Utility Token on Base Mainnet for Product Settlement

RSS feed: Latest on Block3Wire Latest on Block3Wire

  • The Algorithmic Monographs: A Five-Volume Civil Code for the Age of Autonomous Intelligence
  • Ali Sadhik Shaik: Practitioner, Scholar, and Author – Focused on the Governance of Intelligent Systems
  • The Klyrox Protocol: A Decentralized Framework to Close the AI Accountability Gap
  • Covo Finance: Revolutionary Crypto Leverage Trading Platform
  • WorldStrides and HEX Announce Partnership to Offer High School and University Students Innovative Courses Designed to Improve Their Outlook in the Digital Age

RSS feed: Latest on Meta3Wire Latest on Meta3Wire

  • The Algorithmic Monographs: A Five-Volume Civil Code for the Age of Autonomous Intelligence
  • Ali Sadhik Shaik: Practitioner, Scholar, and Author – Focused on the Governance of Intelligent Systems
  • The Klyrox Protocol: A Decentralized Framework to Close the AI Accountability Gap
  • Thumbtack Honored as a 2023 Transform Awards Winner
  • Accenture Invests in Looking Glass to Accelerate Shift from 2D to 3D
Web3Wire

Web3Wire is your go-to source for the latest insights and updates in Web3, Metaverse, Blockchain, AI, Cryptocurrencies, DeFi, NFTs, and Gaming. We provide comprehensive coverage through news, press releases, event updates, and research articles, keeping you informed about the rapidly evolving digital world.

  • About Web3Wire
  • Founder’s Note
  • Web3Wire NFTs – The Web3 Collective
  • .w3w TLD
  • $W3W Token
  • Web3Wire DAO
  • Event Partners
  • Community Partners
  • Our Media Network
  • Media Kit
  • RSS Feeds
  • Contact Us

Crypto Coins

  • Top 10 Coins
  • Top 50 Coins
  • Top 100 Coins
  • All Coins – Marketcap
  • Crypto Coins Heatmap

Crypto Exchanges

  • Top 10 Exchanges
  • Top 50 Exchanges
  • Top 100 Exchanges
  • All Crypto Exchanges

Crypto Stocks

  • Blockchain Stocks
  • NFT Stocks
  • Metaverse Stocks
  • Artificial Intelligence Stocks

Web3Wire Whitepaper | Tokenomics

Web3 Resources

  • Top Web3 and Crypto Youtube Channels
  • Latest Crypto News
  • Latest DeFi News
  • Latest Web3 News

Blockchain Resources

  • Blockchain and Web3 Resources
  • Decentralized Finance (DeFi) – Research Reports
  • All Crypto Whitepapers

Metaverse Resources

  • AR VR and Metaverse Resources
  • Metaverse Courses
Claim your space in Web3 with .w3w!

The Klyrox Protocol | The Algorithmic Monographs

Top 50 Web3 Blogs and Websites
Web3Wire Podcast on Spotify Web3Wire Podcast on Amazon Music 
Web3Wire - Web3 and Blockchain - News, Events and Press Releases | Product Hunt
Web3Wire on Google News

Media Portfolio: Block3Wire | Meta3Wire

  • Privacy Policy
  • Terms of Use
  • Disclaimer
  • Sitemap
  • For Search Engines
  • Crypto Sitemap
  • Exchanges Sitemap

© 2024 Web3Wire. We strongly recommend our readers to DYOR, before investing in any cryptocurrencies, blockchain projects, or ICOs, particularly those that guarantee profits.

Welcome Back!

Login to your account below

Forgotten Password?

Retrieve your password

Please enter your username or email address to reset your password.

Log In

Add New Playlist

No Result
View All Result
  • Coins
    • Top 10 Cryptocurrencies
    • Top 50 Cryptocurrencies
    • Top 100 Cryptocurrencies
    • All Coins
  • Exchanges
    • Top 10 Cryptocurrency Exchanges
    • Top 50 Cryptocurrency Exchanges
    • Top 100 Cryptocurrency Exchanges
    • All Crypto Exchanges
  • Stocks
    • Blockchain Stocks
    • NFT Stocks
    • Metaverse Stocks
    • Artificial Intelligence Stocks

© 2024 Web3Wire. We strongly recommend our readers to DYOR, before investing in any cryptocurrencies, blockchain projects, or ICOs, particularly those that guarantee profits.

This website uses cookies. By continuing to use this website you are giving consent to cookies being used. Visit our Privacy and Cookie Policy.